BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32692906)

  • 1. O-glycans on death receptors in cells modulate their sensitivity to TRAIL-induced apoptosis through affecting on their stability and oligomerization.
    Jiang Y; Wen T; Yan R; Kim SR; Stowell SR; Wang W; Wang Y; An G; Cummings RD; Ju T
    FASEB J; 2020 Sep; 34(9):11786-11801. PubMed ID: 32692906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cosmc transfection decreases malignant behavior of Tn
    Ding R; Hu X; Hu W; Du Z; Huang P; Wang M; Sheng J; Ma Y; Wang A; Luan X; Dong M; Cao Q; Zou Y; Hu T
    Aging (Albany NY); 2021 Oct; 13(19):23393-23406. PubMed ID: 34644263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
    Hofmann BT; Schlüter L; Lange P; Mercanoglu B; Ewald F; Fölster A; Picksak AS; Harder S; El Gammal AT; Grupp K; Güngör C; Drenckhan A; Schlüter H; Wagener C; Izbicki JR; Jücker M; Bockhorn M; Wolters-Eisfeld G
    Mol Cancer; 2015 May; 14():109. PubMed ID: 26021314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Cosmc connection to the Tn antigen in cancer.
    Ju T; Aryal RP; Kudelka MR; Wang Y; Cummings RD
    Cancer Biomark; 2014 Jan; 14(1):63-81. PubMed ID: 24643043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycan elongation beyond the mucin associated Tn antigen protects tumor cells from immune-mediated killing.
    Madsen CB; Lavrsen K; Steentoft C; Vester-Christensen MB; Clausen H; Wandall HH; Pedersen AE
    PLoS One; 2013; 8(9):e72413. PubMed ID: 24039759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morniga-G, a T/Tn-Specific Lectin, Induces Leukemic Cell Death via Caspase and DR5 Receptor-Dependent Pathways.
    Poiroux G; Barre A; Simplicien M; Pelofy S; Segui B; Van Damme EJM; Rougé P; Benoist H
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30626136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Death receptor 5 is activated by fucosylation in colon cancer cells.
    Zhang B; van Roosmalen IAM; Reis CR; Setroikromo R; Quax WJ
    FEBS J; 2019 Feb; 286(3):555-571. PubMed ID: 30589515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated antigens: Tn antigen, sTn antigen, and T antigen.
    Fu C; Zhao H; Wang Y; Cai H; Xiao Y; Zeng Y; Chen H
    HLA; 2016 Dec; 88(6):275-286. PubMed ID: 27679419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tn and sialyl-Tn antigens, aberrant O-glycomics as human disease markers.
    Ju T; Wang Y; Aryal RP; Lehoux SD; Ding X; Kudelka MR; Cutler C; Zeng J; Wang J; Sun X; Heimburg-Molinaro J; Smith DF; Cummings RD
    Proteomics Clin Appl; 2013 Oct; 7(9-10):618-31. PubMed ID: 23857728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic silencing of the chaperone Cosmc in human leukocytes expressing tn antigen.
    Mi R; Song L; Wang Y; Ding X; Zeng J; Lehoux S; Aryal RP; Wang J; Crew VK; van Die I; Chapman AB; Cummings RD; Ju T
    J Biol Chem; 2012 Nov; 287(49):41523-33. PubMed ID: 23035125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DR4-Ser424
    Lee H; Oh Y; Jeon YJ; Lee SY; Kim H; Lee HJ; Jung YK
    Cancer Res; 2019 Jun; 79(11):2839-2852. PubMed ID: 30987996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of Cosmc, T-synthase and mucins in Tn-positive colorectal cancers.
    Sun X; Ju T; Cummings RD
    BMC Cancer; 2018 Aug; 18(1):827. PubMed ID: 30115016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro-survival effects by NF-κB, Akt and ERK(1/2) and anti-apoptosis actions by Six1 disrupt apoptotic functions of TRAIL-Dr4/5 pathway in ovarian cancer.
    Yang J; Li G; Zhang K
    Biomed Pharmacother; 2016 Dec; 84():1078-1087. PubMed ID: 27780136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of TNF-Related Apoptosis-Inducing Ligand Signaling by Glycosylation.
    Micheau O
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29498673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cosmc is an essential chaperone for correct protein O-glycosylation.
    Wang Y; Ju T; Ding X; Xia B; Wang W; Xia L; He M; Cummings RD
    Proc Natl Acad Sci U S A; 2010 May; 107(20):9228-33. PubMed ID: 20439703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL.
    Wagner KW; Punnoose EA; Januario T; Lawrence DA; Pitti RM; Lancaster K; Lee D; von Goetz M; Yee SF; Totpal K; Huw L; Katta V; Cavet G; Hymowitz SG; Amler L; Ashkenazi A
    Nat Med; 2007 Sep; 13(9):1070-7. PubMed ID: 17767167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Tn antigen-structural simplicity and biological complexity.
    Ju T; Otto VI; Cummings RD
    Angew Chem Int Ed Engl; 2011 Feb; 50(8):1770-91. PubMed ID: 21259410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cosmc is required for T cell persistence in the periphery.
    Cutler CE; Jones MB; Cutler AA; Mener A; Arthur CM; Stowell SR; Cummings RD
    Glycobiology; 2019 Oct; 29(11):776-788. PubMed ID: 31317176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations Enhancing Selectivity of Antitumor Cytokine TRAIL to DR5 Receptor Increase Its Cytotoxicity against Tumor Cells.
    Gasparian ME; Bychkov ML; Yagolovich AV; Dolgikh DA; Kirpichnikov MP
    Biochemistry (Mosc); 2015 Aug; 80(8):1080-91. PubMed ID: 26547077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional assays for the molecular chaperone cosmc.
    Ju T; Cummings RD
    Methods Enzymol; 2010; 479():107-22. PubMed ID: 20816162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.